MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans

MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans

Strategies to enhance the induction of high magnitude T cell responses through vaccination are urgently needed. Major histocompatibility complex (MHC) class II–associated invariant chain (Ii) plays a critical role in antigen presentation, forming MHC class II peptide complexes for the generation of...

Bibliografske podrobnosti
Main Authors:	Esposito, I, Cicconi, P, D'Alise, AM, Brown, A, Esposito, M, Swadling, L, Holst, PJ, Bassi, MR, Stornaiuolo, M, Mori, F, Vassilev, V, Li, W, Donnison, T, Gentile, C, Turner, B, von Delft, A, Del Sorbo, M, Barra, F, Contino, AM, Abbate, A, Novellino, E, Thomsen, AR, Christensen, JP, Lahm, A, Grazioli, F, Ammendola, V, Siani, L, Colloca, S, Klenerman, P, Nicosia, A, Dorrell, L, Folgori, A, Capone, S, Barnes, E
Drugi avtorji:	PEACHI Consortium
Format:	Journal article
Jezik:	English
Izdano:	American Association for the Advancement of Science 2020

Podobne knjige/članki

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans
od: Kelly, C, et al.
Izdano: (2016)

Chronic Hepatitis C Virus infection subverts vaccine induced T-cell immunity in humans.
od: Kelly, C, et al.
Izdano: (2016)

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
od: Swadling, L, et al.
Izdano: (2014)

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates
od: Angiolo Pierantoni, et al.
Izdano: (2015-01-01)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
od: Capone, S, et al.
Izdano: (2010)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
od: Capone, S, et al.
Izdano: (2010)

A novel vaccine strategy employing serologically different chimpanzee adenoviral vectors for the prevention of HIV-1 and HCV coinfection
od: Hartnell, F, et al.
Izdano: (2019)

Highly immunogenic virally vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection
od: Swadling, L, et al.
Izdano: (2016)

Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection
od: Swadling, L, et al.
Izdano: (2016)

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man
od: Barnes, E, et al.
Izdano: (2012)

A highly immunogenic novel genetic vaccine against HCV
od: Del Sorbo, M, et al.
Izdano: (2012)

Hepatitis Hide and Seek
od: Barnes, E, et al.
Izdano: (2012)

Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors
od: Fulvia Troise, et al.
Izdano: (2024-03-01)

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species.
od: Colloca, S, et al.
Izdano: (2012)

Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.
od: Federico Napolitano, et al.
Izdano: (2021-04-01)

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection
od: Felicity Hartnell, et al.
Izdano: (2019-01-01)

Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes
od: Donnison, T, et al.
Izdano: (2020)

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
od: Folgori, A, et al.
Izdano: (2009)

A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
od: Kelly, C, et al.
Izdano: (2011)

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
od: Leo Swadling, et al.
Izdano: (2016-08-01)

Historical analysis of rainfall-triggered rockfalls: the case study of the disaster of the ancient hydrothermal Sclafani Spa (Madonie Mts, northern-central Sicily, Italy) in 1851
od: A. Contino, et al.
Izdano: (2017-12-01)

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.
od: Reyes-Sandoval, A, et al.
Izdano: (2010)

Erratum: Prime-boost immunization with adenoviral and modified vaccinia virus ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses
od: Reyes-Sandoval, A, et al.
Izdano: (2011)

Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8(+) T-Cell Responses, (vol 78, pg 152, 2010)
od: Reyes-Sandoval, A, et al.
Izdano: (2011)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
od: Green, C, et al.
Izdano: (2015)

Formyl-Peptide Receptor 2 Signaling Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming of Lung Cancer Cells
od: Tiziana Pecchillo Cimmino, et al.
Izdano: (2022-08-01)

Formyl-peptide receptor 2 signalling triggers aerobic metabolism of glucose through Nox2-dependent modulation of pyruvate dehydrogenase activity
od: Tiziana Pecchillo Cimmino, et al.
Izdano: (2023-10-01)

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
od: Barnes, E, et al.
Izdano: (2011)

Pathophysiology of ischaemic heart disease
od: Pocock, MO, et al.
Izdano: (2017)

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
od: Alessandra Vitelli, et al.
Izdano: (2017-12-01)

Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
od: Anna Morena D’Alise, et al.
Izdano: (2019-06-01)

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
od: Barnes, E, et al.
Izdano: (2009)

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.
od: Spencer, A, et al.
Izdano: (2014)

Formyl Peptide Receptor 2-Dependent cPLA2 and 5-LOX Activation Requires a Functional NADPH Oxidase
od: Tiziana Pecchillo Cimmino, et al.
Izdano: (2024-02-01)

Targeting HIV-1 Where It Hurts
od: Ahmed, T, et al.
Izdano: (2013)

The HIVconsv Vaccines Induce Polyfunctional and Highly Proliferative T Cells that Control In Vitro HIV Replication: HIV-CORE002 Phase-I Clinical Trial
od: Ondondo, B, et al.
Izdano: (2013)

IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
od: Kelly, C, et al.
Izdano: (2012)

Entanglement entropy in conformal quantum mechanics
od: Michele Arzano, et al.
Izdano: (2023-10-01)

Innovating through Clusters
od: Chiara D'Alise, et al.
Izdano: (2014-11-01)

SoCIAL – training cognition in schizophrenia: a pilot study
od: Palumbo D, et al.
Izdano: (2017-07-01)